Articles
Volume 7 Supplement 2
The Third International Symposium on the Molecular Biology of Breast Cancer
- Meeting abstracts
- from The Third International Symposium on the Molecular Biology of Breast Cancer
- Molde, Norway
- 22-26 June 2005
- Affymetrix, Agilent Technologies, Applied Biosystems, AstraZeneca, Novartis Oncology, Pfizer, Roche Diagnostics (Main Sponsors).
|
N Davidson Breast Cancer Research 2005, 7(Suppl 2):S.01 (17 June 2005) |
|
Stromal and epithelial TGF-β signaling in mammary tumorigenesis HL Moses, N Cheng, A Chytil, AE Gorska, M Aakre, E Forrester, EG Neilson, NA Bhowmick Breast Cancer Research 2005, 7(Suppl 2):S.02-S44 (17 June 2005) |
|
Genomic analysis of human breast cancer in families and populations M-C King Breast Cancer Research 2005, 7(Suppl 2):S.03 (17 June 2005) |
|
Breast Cancer Research 2005, 7(Suppl 2):S.04 (17 June 2005) |
|
ATM mutations associated with breast cancer RA Gatti, P Concannon Breast Cancer Research 2005, 7(Suppl 2):S.05 (17 June 2005) |
|
DNA damage response pathways in cancer causation and treatment MB Kastan, R Kitagawa, CJ Bakkenist Breast Cancer Research 2005, 7(Suppl 2):S.06 (17 June 2005) |
|
SNPS in putative regulatory loci controlling gene expression in cancer VN Kristensen Breast Cancer Research 2005, 7(Suppl 2):S.07 (17 June 2005) |
|
Potential mechanisms whereby estrogens induce breast cancer in women RJ Santen, W Yue, J-P Wang Breast Cancer Research 2005, 7(Suppl 2):S.08 (17 June 2005) |
|
The future of breast cancer prevention A Howell, A Sims, M Harvie, KR Ong, G Evans, R Clarke Breast Cancer Research 2005, 7(Suppl 2):S.09 (17 June 2005) |
|
Targeting estrogen to kill ER-positive and ER-negative breast cancer VC Jordan Breast Cancer Research 2005, 7(Suppl 2):S.10 (17 June 2005) |
|
ERβ in normal and malignant breast J-Å Gustafsson, G Cheng, M Warner Breast Cancer Research 2005, 7(Suppl 2):S.11 (17 June 2005) |
|
Molecular approaches to understanding pregnancy-induced protection against breast cancer CM Blakely, SE Moody, A Stoddard, E Tombler, C Liu, LA Chodosh Breast Cancer Research 2005, 7(Suppl 2):S.12 (17 June 2005) |
|
Predicting response/resistance to endocrine therapy for breast cancer WR Miller, TJ Anderson, D Evans, A Krause, JM Dixon Breast Cancer Research 2005, 7(Suppl 2):S.13 (17 June 2005) |
|
Genetic and epigenetic changes in early carcinogenesis TD Tlsty Breast Cancer Research 2005, 7(Suppl 2):S.14 (17 June 2005) |
|
MJ Bissell, C Myers, G Lee, E Lee, A Rizki, S Mian, J Gray, D Radisky Breast Cancer Research 2005, 7(Suppl 2):S.15 (17 June 2005) |
|
Genomic and transcriptional events associated with poor clinical responses to conventional therapies K Chin, S Devries, J Fridlyand, P Spellman, W-L Kuo, A Lapuk, R Neve, T Tokuyasu, C Kingsley, S Dairkee, K Chew, A Jain, BM Ljung, L Esserman, F Waldman, JW Gray Breast Cancer Research 2005, 7(Suppl 2):S.16 (17 June 2005) |
|
The role of the tumor microenvironment in breast cancer progression H Min, J Yao, M Allinen, L Cai, K Polyak Breast Cancer Research 2005, 7(Suppl 2):S.17 (17 June 2005) |
|
Biological features and xenograft models of a very early human premalignant breast lesion S Lee, Y Wu, SK Mohsin, D Medina, DC Allred Breast Cancer Research 2005, 7(Suppl 2):S.18 (17 June 2005) |
|
Regulation of epithelial cell polarity during carcinogenesis SK Muthuswamy Breast Cancer Research 2005, 7(Suppl 2):S.19 (17 June 2005) |
|
Expression profiling of peripheral blood cells for early detection A-L Børresen-Dale, P Sharma Breast Cancer Research 2005, 7(Suppl 2):S.20 (17 June 2005) |
|
Stem cells in human breast development and cancer M Wicha, G Dontu, S Liu, I Mantle Breast Cancer Research 2005, 7(Suppl 2):S.21 (17 June 2005) |
|
Molecular distinctions among SS Jeffrey Breast Cancer Research 2005, 7(Suppl 2):S.22 (17 June 2005) |
|
Insulin-like growth factor regulation of mammary gland development and tumorigenesis AV Lee Breast Cancer Research 2005, 7(Suppl 2):S.23 (17 June 2005) |
|
Targeting the cell cycle for prognosis and therapy of breast cancer K Keyomarsi, S Akli Breast Cancer Research 2005, 7(Suppl 2):S.24 (17 June 2005) |
|
AB Pardee, PV Reddy, DK Biswas, CJ Li Breast Cancer Research 2005, 7(Suppl 2):S.25 (17 June 2005) |
|
J Hicks, V Grubor, N Navin, P Lundin, S Månér, T Hägerström, L Skoog, M Wigler, A Zetterberg Breast Cancer Research 2005, 7(Suppl 2):S.26 (17 June 2005) |
|
Tailored therapies based upon tumor subtype biology CM Perou Breast Cancer Research 2005, 7(Suppl 2):S.27 (17 June 2005) |
|
Expression profiling as a prognostic and predictive factor in breast cancer LJ van 't Veer Breast Cancer Research 2005, 7(Suppl 2):S.28 (17 June 2005) |
|
Genomic profiling of breast cancer Å Borg Breast Cancer Research 2005, 7(Suppl 2):S.29 (17 June 2005) |
|
GL Bond, AJ Levine Breast Cancer Research 2005, 7(Suppl 2):S.30 (17 June 2005) |
|
Evading p53 action during tumor development and therapy SW Lowe Breast Cancer Research 2005, 7(Suppl 2):S.31 (17 June 2005) |
|
TP53 and additional pathways in therapy resistance PE Lønning Breast Cancer Research 2005, 7(Suppl 2):S.32 (17 June 2005) |
|
Dynamic imaging of plasticity and escape in tumor cell invasion P Friedl Breast Cancer Research 2005, 7(Suppl 2):S.33 (17 June 2005) |
|
Role of HER2 in local relapse and metastasis S Ménard Breast Cancer Research 2005, 7(Suppl 2):S.34 (17 June 2005) |
|
Molecular profiling of early breast cancer in relation to detection of micrometastases and outcome B Naume, T Sørlie Breast Cancer Research 2005, 7(Suppl 2):S.35 (17 June 2005) |
|
Update on HER2-directed therapy D Slamon Breast Cancer Research 2005, 7(Suppl 2):S.36 (17 June 2005) |
|
Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer M Dowsett Breast Cancer Research 2005, 7(Suppl 2):S.37 (17 June 2005) |
|
Development of CDK inhibitors as cancer therapeutics D Lane Breast Cancer Research 2005, 7(Suppl 2):S.38 (17 June 2005) |
|
D Botstein Breast Cancer Research 2005, 7(Suppl 2):S.39 (17 June 2005) |
|
The search for low-penetrance breast cancer genes BAJ Ponder, A Cebrian, AM Dunning, DF Easton, F Lesueur, C Luccarini, PDP Pharoah Breast Cancer Research 2005, 7(Suppl 2):S.40 (17 June 2005) |
|
Functional genomic approaches to breast cancer R Bernards Breast Cancer Research 2005, 7(Suppl 2):S.41 (17 June 2005) |
|
Proteomic approaches to early detection of breast cancer JE Celis, P Gromov, JMA Moreira, T Cabezón, E Friis, F Rank, I Gromova Breast Cancer Research 2005, 7(Suppl 2):S.42 (17 June 2005) |
|
O Kallioniemi Breast Cancer Research 2005, 7(Suppl 2):S.43 (17 June 2005) |
|
Envisioning new targets and new approaches for molecular-based cancer therapeutics JA Tainer Breast Cancer Research 2005, 7(Suppl 2):S.44 (17 June 2005) |
|
Cigarette smoking and breast cancer risk among non-drinking women IT Gram, T Braaten, HO Adami, E Lund, E Weiderpass Breast Cancer Research 2005, 7(Suppl 2):P1.01 (17 June 2005) |
|
Mutation screening of S Cierniková, M Tomka, M Kovac, V Stevurkova, V Bella, J Novotny, V Zajac Breast Cancer Research 2005, 7(Suppl 2):P1.02 (17 June 2005) |
|
J Pamuła, M Krześniak, H Zientek, WP Pękala, M Rusin, E Grzybowska Breast Cancer Research 2005, 7(Suppl 2):P1.03 (17 June 2005) |
|
F Baudi, AM Lavecchia, B Quaresima, MC Faniello, L De Paola, W D'Amico, F Fabiani, G Cuda, FS Costanzo, S Venuta Breast Cancer Research 2005, 7(Suppl 2):P1.04 (17 June 2005) |
|
M Van Ghelue, M Ingebrigtsen, HMF Riise Stensland, L Mæhle, J Apold, P Møller, V Marton, C Jonsrud Breast Cancer Research 2005, 7(Suppl 2):P1.05 (17 June 2005) |
|
L Foretova, M Lukesova, P Vasickova, M Navratilova, H Pavlu, J Kuklova, V Urbankova, D Hanouskova, B Dvorackova, E Machackova Breast Cancer Research 2005, 7(Suppl 2):P1.06 (17 June 2005) |
|
Genetic determinants of breast cancer characteristics and outcome in women under 50 years of age MK Schmidt, A van der Plas, SR de Kemp, S Klaver, B Nota, B Maertzdorf, R de Groot, R Udo, VTHBM Smit, A Broeks, JL Peterse, FE van Leeuwen, RAEM Tollenaar, LJ van 't Veer Breast Cancer Research 2005, 7(Suppl 2):P1.07 (17 June 2005) |
|
FE Van Leeuwen, N Andrieu, DF Easton, J Chang-Claude, R Brohet, E Cardis, AC Antoniou, S Peock, C Nogues, MA Rookus, DE Goldgar, EMBRACE, GENEPSO, GEO-HEBON and the IBCCS collaborators' group Breast Cancer Research 2005, 7(Suppl 2):P1.08 (17 June 2005) |
|
Clinical outcome for MK Schmidt, TC van Sprundel, MA Rookus, R Brohet, CJ van Asperen, EJTh Rutgers, RAEM Tollenaar, LJ van 't Veer Breast Cancer Research 2005, 7(Suppl 2):P1.09 (17 June 2005) |
|
Oral contraceptives and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS) MA Rookus, RM Brohet, N Andrieu, AC Antoniou, J Chang-Claude, DF Easton, S Peock, C Noguès, FE van Leeuwen, DE Goldgar, the IBCCS Collaborating Group Breast Cancer Research 2005, 7(Suppl 2):P1.10 (17 June 2005) |
|
RA Oldenburg, K Kroeze-Jansema, JJ Houwing, J Kraan, JG Klijn, N Hoogerbrugge, MJ Ligtenberg, CJ van Asperen, HF Vasen, H Meijers-Heijboer, CJ Cornelisse, P Devilee Breast Cancer Research 2005, 7(Suppl 2):P1.11 (17 June 2005) |
|
BA Nexø, U Vogel, K Overvad, O Raaschou-Nielsen, A Tjønneland Breast Cancer Research 2005, 7(Suppl 2):P1.12 (17 June 2005) |
|
DNA polymorphisms of several genes and predisposition to breast cancer D Zaletayev, V Artamonov, D Mikhaylenko, L Lyubchenko, M Nemtsova Breast Cancer Research 2005, 7(Suppl 2):P1.13 (17 June 2005) |
|
A Vega, A Salas, C Phillips, B Sobrino, B Carracedo, C Ruíz-Ponte, R Rodríguez-López, G Rivas, J Benítez, A Carracedo Breast Cancer Research 2005, 7(Suppl 2):P1.14 (17 June 2005) |
|
H Edvardsen, B Kulle, GI Grenaker-Alnæs, AC Syvänen, AL Børresen-Dale, A Frigessi, VN Kristensen Breast Cancer Research 2005, 7(Suppl 2):P1.15 (17 June 2005) |
|
Comparison of methods for pharmacogenomics: SNaPshot, SNPstream UHT, Nanogen, and RFLP GIG Alnæs, FE Johansen, SH Nordgard, B Hihn, H Edvardsen, VI Hilden, PE Lønning, A-C Syvänen, A-L Børresen-Dale, VN Kristensen Breast Cancer Research 2005, 7(Suppl 2):P1.16 (17 June 2005) |
|
JA Rønneberg, J Tost, GI Grenaker-Alnæs, T Sørlie, T Kristensen, I Gut, A-L Børresen-Dale, VN Kristensen Breast Cancer Research 2005, 7(Suppl 2):P1.17 (17 June 2005) |
|
The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk B Frank, K Hemminki, M Wirtenberger, JL Bermejo, P Bugert, R Klaes, RK Schmutzler, B Wappenschmidt, CR Bartram, B Burwinkel Breast Cancer Research 2005, 7(Suppl 2):P1.18 (17 June 2005) |
|
Alpha-1 antitrypsin genotypes in breast cancer patients Z El-Akawi, M Nusier, DH Sawalha Breast Cancer Research 2005, 7(Suppl 2):P1.19 (17 June 2005) |
|
Association of B Burwinkel, M Wirtenberger, B Frank, R Klaes, RK Schmutzler, E Grzybowska, A Försti, JL Bermejo, P Bugert, B Wappenschmidt, D Butkiewicz, J Pamula, W Pekala, H Zientek, D Mielzynska, E Siwinska, CR Bartram, K Hemminki Breast Cancer Research 2005, 7(Suppl 2):P1.20 (17 June 2005) |
|
Polymorphisms in the CRK gene and their association with breast cancer risk K Wagner, K Hemminki, E Grzybowska, A Försti Breast Cancer Research 2005, 7(Suppl 2):P1.21 (17 June 2005) |
|
High-density screening of the A Salas, A Vega, M Torres, I Quintela, C Phillips, R Rodríguez-López, G Rivas, J Benítez, A Carracedo Breast Cancer Research 2005, 7(Suppl 2):P1.22 (17 June 2005) |
|
ZBTB7 HapMap in a worldwide population study A Salas, A Vega, C Phillips, M Torres, I Quintela, A Carracedo Breast Cancer Research 2005, 7(Suppl 2):P1.23 (17 June 2005) |
|
A critical need for molecular markers of breast cancer risk and risk reduction KA Johnson, LG Ford Breast Cancer Research 2005, 7(Suppl 2):P1.24 (17 June 2005) |
|
V Dumeaux, J Johansen, AL Børresen-Dale, E Lund Breast Cancer Research 2005, 7(Suppl 2):P2.01 (17 June 2005) |
|
Effects of oestrogen on gene expression in the epithelium and stroma of the normal human breast AH Sims, KR Ong, CL Wilson, A Howell, RB Clarke Breast Cancer Research 2005, 7(Suppl 2):P2.02 (17 June 2005) |
|
Mammary development fate and breast cancer risk D Medina Breast Cancer Research 2005, 7(Suppl 2):P2.03 (17 June 2005) |
|
Y Hu, S Aiyar, W Yue, S Ghosh, Y Lu, R Li Breast Cancer Research 2005, 7(Suppl 2):P2.04 (17 June 2005) |
|
B-W Park, M-K Heo, S-O Park, S-I Kim, K-S Kim, C-H Park Breast Cancer Research 2005, 7(Suppl 2):P2.05 (17 June 2005) |
|
L-A Martin, S Pancholi, I Farmer, SRD Johnston, M Dowsett Breast Cancer Research 2005, 7(Suppl 2):P2.06 (17 June 2005) |
|
Molecular prediction of tamoxifen resistance in breast cancer M Kok, TMC van den Berg, LJ Delahaye, A Floore, AM Glas, JL Peterse, LFA Wessels, LJ van 't Veer, SC Linn Breast Cancer Research 2005, 7(Suppl 2):P2.07 (17 June 2005) |
|
S Pancholi, A Lykkesfeldt, SRD Johnston, M Dowsett, L-A Martin Breast Cancer Research 2005, 7(Suppl 2):P2.08 (17 June 2005) |
|
O Engebraaten, GO Hjortland, M Martinsen, T Halvorsen, Ø Fodstad, AH Ree Breast Cancer Research 2005, 7(Suppl 2):P2.09 (17 June 2005) |
|
VM Bowers-Morrow, SO Ali Breast Cancer Research 2005, 7(Suppl 2):P2.10 (17 June 2005) |
|
Identification of molecular apocrine breast tumours by microarray analysis P Farmer, H Bonnefoi, V Becette, M Tubiana-Hulin, P Fumoleau, D Larsimont, G MacGrogan, J Bergh, D Cameron, D Goldstein, S Duss, A-L Nicoulaz, M Fiche, C Brisken, M Delorenzi, R Iggo Breast Cancer Research 2005, 7(Suppl 2):P2.11 (17 June 2005) |
|
Gene expression profiling to identify parity-induced changes in the human mammary gland I Verlinden, N Güngör, J Janssens, L Michiels Breast Cancer Research 2005, 7(Suppl 2):P3.01 (17 June 2005) |
|
The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells RS Muraoka-Cook, C Husted, D Hunter, L Miraglia, HS Earp Breast Cancer Research 2005, 7(Suppl 2):P3.02 (17 June 2005) |
|
Essential functions of the Janus kinase 2 (Jak2) during mammary gland development and tumorigenesis K Sakamoto, A Krempler, AA Triplett, J Zhu, H Rui, K-U Wagner Breast Cancer Research 2005, 7(Suppl 2):P3.03 (17 June 2005) |
|
N Dumont, YG Crawford, P Reynolds, TD Tlsty Breast Cancer Research 2005, 7(Suppl 2):P3.04 (17 June 2005) |
|
G Bonizzi, A Cicalese, B Giulini, S Pesce, A Gobbi, S Pece, PP Di Fiore, PG Pelicci Breast Cancer Research 2005, 7(Suppl 2):P3.05 (17 June 2005) |
|
Myoepithelial cell layer disruption and human breast cancer invasion YG Man, QX Sang Breast Cancer Research 2005, 7(Suppl 2):P3.06 (17 June 2005) |
|
Imprint as a reliable diagnostic tool in breast cancer and possible usefulness for research purposes E Mortensen, L Hansen, JO Frantzen, S Klenow, N Bjurstam, RH Paulssen Breast Cancer Research 2005, 7(Suppl 2):P3.07 (17 June 2005) |
|
Immortalization-associated gene signature in breast cancer SH Dairkee, M Nicolau, S Champion, Y Ji, A Sayeed, Z Meng, J Demeter, SS Jeffrey Breast Cancer Research 2005, 7(Suppl 2):P3.08 (17 June 2005) |
|
HJ Lee, SH Kim Breast Cancer Research 2005, 7(Suppl 2):P4.01 (17 June 2005) |
|
S Yoon, M-Y Lee, B-W Park, K-S Kim Breast Cancer Research 2005, 7(Suppl 2):P4.02 (17 June 2005) |
|
Altered signaling in anti-estrogen-resistant human breast cancer cells AE Lykkesfeldt, T Frogne, JS Jepsen, CK Fog, SS Larsen Breast Cancer Research 2005, 7(Suppl 2):P4.03 (17 June 2005) |
|
HIN-1, an inhibitor of cell growth, invasion, and AKT1 activation IE Krop, MT Parker, N Qimron, D Porter, K Polyak Breast Cancer Research 2005, 7(Suppl 2):P4.04 (17 June 2005) |
|
Expression of STAT1 target genes and interferon gamma in human mammary carcinoma tissue W Doppler, C Marth, G Daxenbichler, P Obrist, C Berlato Breast Cancer Research 2005, 7(Suppl 2):P4.05 (17 June 2005) |
|
M Shehata, R Boutros, RK Bright, J Byrne Breast Cancer Research 2005, 7(Suppl 2):P4.06 (17 June 2005) |
|
Functional characterization of genes involved in the development of breast cancer E Gjernes, GL Størvold, H Askautrud, A-L Børresen-Dale, CM Perou, E Frengen Breast Cancer Research 2005, 7(Suppl 2):P4.07 (17 June 2005) |
|
Breast Cancer Research 2005, 7(Suppl 2):P4.08 (17 June 2005) |
|
Deletions at the chromosome 3 common eliminated region 1 on 3p21.3 in human breast tumors ThE Petursdottir, U Thorsteinsdottir, JG Jonasson, PH Moller, C Huiping, J Bjornsson, V Egilsson, S Imreh, S Ingvarsson Breast Cancer Research 2005, 7(Suppl 2):P4.09 (17 June 2005) |
|
A Husdal, G Bukholm, IRK Bukholm Breast Cancer Research 2005, 7(Suppl 2):P4.10 (17 June 2005) |
|
IL-8 is a novel marker for breast cancer C Chavey, A Freund, S Durand, G Lazennec Breast Cancer Research 2005, 7(Suppl 2):P4.11 (17 June 2005) |
|
Lack of evidence for nuclear IGFBP5 in mammary epithelial cells C Berlato, A Jurgeit, S Geley, W Doppler Breast Cancer Research 2005, 7(Suppl 2):P4.12 (17 June 2005) |
|
S Seitz, E Korsching, J Weimer, A Jacobsen, N Arnold, A Meindl, W Arnold, D Gustavus, C Klebig, I Petersen, S Scherneck Breast Cancer Research 2005, 7(Suppl 2):P4.13 (17 June 2005) |
|
J Strissel, S Seitz, W Arnold, J Weimer, A Jacobsen, N Arnold, S Scherneck Breast Cancer Research 2005, 7(Suppl 2):P4.14 (17 June 2005) |
|
A Bakin, A Varga, Q Zheng, A Safina Breast Cancer Research 2005, 7(Suppl 2):P4.15 (17 June 2005) |
|
Hypermethylation of cyclin D2 and DAP kinase is associated with the lobular subtype of breast cancer U Lehmann, P Ahrens, LU Wingen, B Schlegelberger, F Länger, H Kreipe Breast Cancer Research 2005, 7(Suppl 2):P4.16 (17 June 2005) |
|
Methylation profiling of carcinogenesis-associated genes in sporadic breast cancer M Nemtsova, V Zemlyakova, E Kusnetsova, V Strelnikov, L Lyubchenko, D Zaletayev Breast Cancer Research 2005, 7(Suppl 2):P4.17 (17 June 2005) |
|
Expression profiling of Wnt pathway genes in breast cancer K Benhaj, B Gur, B Bozkurt, I Yulug, C Akcali, M Ozturk Breast Cancer Research 2005, 7(Suppl 2):P4.18 (17 June 2005) |
|
Real-time PCR-based expression profiling of BRCA1-induced genes in primary breast tumors B Gur, B Bozkurt, O Konu, S Seckin, IG Yulug Breast Cancer Research 2005, 7(Suppl 2):P4.19 (17 June 2005) |
|
Development of a rapid screening approach for candidate gene sets in cancer R Wittig, R Salowsky, S Blaich, S Lyer, JS Maa, O Müller, J Mollenhauer, A Poustka Breast Cancer Research 2005, 7(Suppl 2):P4.20 (17 June 2005) |
|
Application of microarray analyses to identify genes involved in radiation-induced fibrosis OK Rødningen, J Alsner, T Hastie, J Overgaard, A-L Børresen-Dale Breast Cancer Research 2005, 7(Suppl 2):P4.21 (17 June 2005) |
|
Gene expression studies in radiation-sensitive cell lines J Aarøe, R Gatti, A-L Børresen-Dale, O Rødningen Breast Cancer Research 2005, 7(Suppl 2):P4.22 (17 June 2005) |
|
Breast tumors induced by high-dose radiation display similar genetic profiles A Broeks, SR de Kemp, W Bakker, LM Braaf, FE van Leeuwen, M Stovall, MK Schmidt, NS Russell, LFA Wessels, LJ van 't Veer Breast Cancer Research 2005, 7(Suppl 2):P4.23 (17 June 2005) |
|
Molecular characterization of breast cell lines: a tool for breast cancer studies E Charafe-Jauffret, C Ginestier, F Monville, J Adélaïde, P Finetti, F Bertucci, L Xerri, J Jacquemier, D Birnbaum Breast Cancer Research 2005, 7(Suppl 2):P4.24 (17 June 2005) |
|
CA Wilson, J Dering, G Bernardo, HM Rong, C Ginther, R Ferdman, AM Cook, R Finn, DJ Slamon Breast Cancer Research 2005, 7(Suppl 2):P4.25 (17 June 2005) |
|
Reproducibility of molecular portraits in early stage breast cancer DSA Nuyten, HY Chang, PO Brown, MJ Van de Vijver Breast Cancer Research 2005, 7(Suppl 2):P4.26 (17 June 2005) |
|
Y Wang, T Sørlie, C Xiao, L-A Macalik, H Johnsen, G Schroth, A-L Børresen-Dale, R Samaha Breast Cancer Research 2005, 7(Suppl 2):P4.27 (17 June 2005) |
|
Lymph node metastases display gene expression profiles of their primary breast carcinomas B Weigelt, LFA Wessels, AJ Bosma, AM Glas, DSA Nuyten, YD He, H Dai, JL Peterse, LJ van 't Veer Breast Cancer Research 2005, 7(Suppl 2):P4.28 (17 June 2005) |
|
U Vinatzer, B Dampier, M Pacher, K Kaserer, C Haslinger, N Schweifer, M Schreiber Breast Cancer Research 2005, 7(Suppl 2):P4.29 (17 June 2005) |
|
Gene expression signature of hereditary breast cancer V Dudaladava, M Jarzab, J Pamula, W Pekala, T Huzarski, J Lubinski, E Grzybowska, K Lisowska Breast Cancer Research 2005, 7(Suppl 2):P4.30 (17 June 2005) |
|
Comparison of the expression profile in breast cancer and ovarian cancer M Jarzab, V Dudaladava, K Simek Breast Cancer Research 2005, 7(Suppl 2):P4.31 (17 June 2005) |
|
I Vanden Bempt, V Vanhentenrijk, M Drijkoningen, C De Wolf-Peeters Breast Cancer Research 2005, 7(Suppl 2):P4.32 (17 June 2005) |
|
C Sotiriou, P Wirapati, S Loi, A Harris, J Bergh, J Smeds, V Praz, P Farmer, B Haibe-Kains, F Lallemand, M Buyse, M Piccart, M Delorenzi Breast Cancer Research 2005, 7(Suppl 2):P4.33 (17 June 2005) |
|
Promoter composition predicts gene classes in microarray expression analyses of breast cancer SH Nordgard, T Sørlie, SJ Chanock, A-L Børresen-Dale, K Gardner, VN Kristensen Breast Cancer Research 2005, 7(Suppl 2):P4.34 (17 June 2005) |
|
NAS Rao, R van den Ham, M van Wolferen, JA Mol Breast Cancer Research 2005, 7(Suppl 2):P4.35 (17 June 2005) |
|
Discovering genetic profiles by array-CGH in familial breast tumors PM Nederlof, E van Beers, S Joosse, FBL Hogervorst, LFA Wessels, P Devilee, C Cornelisse, R Oldenburg, S Verhoef, LJ van 't Veer Breast Cancer Research 2005, 7(Suppl 2):P4.36 (17 June 2005) |
|
J Li, X Zhang, TD Jensen, K Wang, S Kølvraa, L Bolund Breast Cancer Research 2005, 7(Suppl 2):P4.37 (17 June 2005) |
|
Outcome signature genes in breast cancer: is there a unique set? I Kela, L Ein-Dor, G Getz, D Givol, E Domany Breast Cancer Research 2005, 7(Suppl 2):P4.38 (17 June 2005) |
|
Mapping the location of recurring amplicons in array-CGH data OC Lingjærde, K Liestøl, L Baumbusch, HL Størvold, AL Børresen-Dale Breast Cancer Research 2005, 7(Suppl 2):P4.39 (17 June 2005) |
|
Comparative genomic hybridization using oligonucleotide arrays and total genomic DNA MT Barrett, N Sampas, A Ben-Dor, A Scheffer, P Anderson, P Tsang, C Gooden, R Walker, B Curry, R Kincaid, D Lipson, M Bittner, Z Yakhini, PS Meltzer, L Bruhn, S Laderman Breast Cancer Research 2005, 7(Suppl 2):P4.40 (17 June 2005) |
|
DNA copy number changes in breast cancer samples using array-CGH profiling R Argonza-Barrett, W Dorlijn, J Bailey Breast Cancer Research 2005, 7(Suppl 2):P4.41 (17 June 2005) |
|
C Buhlmann, O Mueller, R Salowsky, S Lightfoot Breast Cancer Research 2005, 7(Suppl 2):P4.42 (17 June 2005) |
|
Predicting survival from gene expression data by generalized partial least squares regression HL Størvold, OC Lingjærde Breast Cancer Research 2005, 7(Suppl 2):P4.43 (17 June 2005) |
|
A Langerød, H Zhao, Ø Borgan, JM Nesland, T Hernandez-Boussard, IK Bukholm, R Kåresen, AL Børresen-Dale, SS Jeffrey Breast Cancer Research 2005, 7(Suppl 2):P4.44 (17 June 2005) |
|
Å Helland, M Nicolau, Y Ji, A Langerød, DE Sommervoll, A Bergamaschi, JR Pollack, A-L Børresen-Dale, SS Jeffrey Breast Cancer Research 2005, 7(Suppl 2):P4.45 (17 June 2005) |
|
Mutant p53 exerts its gain of function through activation of the NF-κB pathway A Damalas, L Weis, SH Nordgard, VN Kristensen, K Gardner, G Cheng, C Gelinas, M Levrero, S Strano, AL Børresen-Dale, V Rotter, M Oren, G Blandino Breast Cancer Research 2005, 7(Suppl 2):P4.46 (17 June 2005) |
|
Expression of wild-type and mutated LO Baumbusch, S Myhre, A Langerød, A Bergamaschi, H Johnsen, S Geisler, PE Lønning, A-L Børresen-Dale Breast Cancer Research 2005, 7(Suppl 2):P4.47 (17 June 2005) |
|
Independent prognostic value of somatic M Olivier, A Langerød, P Carrieri, J Bergh, S Klaar, J Eyfjord, C Theillet, C Rodriguez, R Lidereau, I Bièche, J Varley, Y Bignon, N Uhrhammer, R Winqvist, A Jukkola-Vuorinen, D Niederacher, S Kato, C Ishioka, P Hainaut, A-L Børresen-Dale Breast Cancer Research 2005, 7(Suppl 2):P4.48 (17 June 2005) |
|
Prognostic value genotypes and LOH at M Kyndi, J Alsner, LL Hansen, FB Sørensen, J Overgaard Breast Cancer Research 2005, 7(Suppl 2):P4.49 (17 June 2005) |
|
Evaluation of the arrayed primer extension resequencing assay for EU Due, H Johnsen, CA Wilson, CJ Fæster, P Vu, A Bergamaschi, P Kringen, AL Børresen-Dale Breast Cancer Research 2005, 7(Suppl 2):P4.50 (17 June 2005) |
|
Cancer gene mutation discovery and detection using array-based resequencing T Tengs, JC Lee, JG Paez, X Zhao, T LaFramboise, G Giannoukos, RK Thomas Breast Cancer Research 2005, 7(Suppl 2):P4.51 (17 June 2005) |
|
A Fabisiewicz, P Kober, M Koptyra, E Brewczynska, R Sienkiewicz-Kozlowska, T Pienkowski, JA Siedlecki Breast Cancer Research 2005, 7(Suppl 2):P5.01 (17 June 2005) |
|
Detection of minimal disease in breast cancer AJ Bosma, H Helgason, L Braaf, S Rodenhuis, LJ van 't Veer Breast Cancer Research 2005, 7(Suppl 2):P5.02 (17 June 2005) |
|
A Gonçalves, B Esterni, F Bertucci, R Sauvan, M Cubizolles, S Granjeaud, C Chabannon, G Houvenaegel, J Jacquemier, X-Y Meng, ET Fung, D Birnbaum, D Maraninchi, P Viens, JP Borg Breast Cancer Research 2005, 7(Suppl 2):P5.03 (17 June 2005) |
|
V Drageset, JM Nesland, B Erikstein, E Skovlund, H Sommer, G Anker, E Wist, S Lundgren, J Bergh, G Kvalheim Breast Cancer Research 2005, 7(Suppl 2):P5.04 (17 June 2005) |
|
JT Erler, SS Jeffrey, AJ Giaccia Breast Cancer Research 2005, 7(Suppl 2):P5.05 (17 June 2005) |
|
M Botelho, I Amendoeira, J Diamond, S Dias, F Schmitt Breast Cancer Research 2005, 7(Suppl 2):P5.06 (17 June 2005) |
|
The extracellular matrix composition and responsiveness to breast carcinoma therapy SM Pupa, WS Argraves, S Cotrupi, S Giuffré, F Castiglioni, S Ménard, E Tagliabue Breast Cancer Research 2005, 7(Suppl 2):P5.07 (17 June 2005) |
|
Characterization of extracellular matrix composition in breast carcinoma A Bergamaschi, E Tagliabue, T Sørlie, J Nesland, R Orlandi, S Ménard, A-L Børresen-Dale Breast Cancer Research 2005, 7(Suppl 2):P5.08 (17 June 2005) |
|
SA Lee, VS Budhram-Mahadeo Breast Cancer Research 2005, 7(Suppl 2):P5.09 (17 June 2005) |
|
Identification of drug targets for the treatment of Basal-like tumors KA Hoadley, CM Perou Breast Cancer Research 2005, 7(Suppl 2):P6.01 (17 June 2005) |
|
Determining the factors affecting breast cancer infectivity by oncolytic adenovirus C Mysinger, C Soria, J Yeh, C O'Shea, L Timmerman, F McCormick Breast Cancer Research 2005, 7(Suppl 2):P6.02 (17 June 2005) |
|
B Sitter, TF Bathen, LR Jensen, D Axelson, J Halgunset, HE Fjosne, S Lundgren, IS Gribbestad Breast Cancer Research 2005, 7(Suppl 2):P7.01 (17 June 2005) |
|
Potentiated phospho-protein networks in cancer cells JM Irish, R Hovland, PO Krutzik, OD Perez, O Bruserud, BT Gjertsen, GP Nolan Breast Cancer Research 2005, 7(Suppl 2):P7.02 (17 June 2005) |
|
A model of the BRCA1/BRCA2 network MA Pujana, J-DJ Han, LM Starita, M Tewari, JS Ahn, V Assmann, WM ElShamy, J-F Rual, R Gelman, K Gunsalus, R Greenberg, B Bohian, N Bertin, N Ayivi-Guedehoussou, KL Nathanson, BL Weber, DE Hill, DM Livingston, JD Parvin, M Vidal Breast Cancer Research 2005, 7(Suppl 2):P7.03 (17 June 2005) |
|
D Zink, R Salowsky, S Haas, C Buhlmann, B Korn Breast Cancer Research 2005, 7(Suppl 2):P7.04 (17 June 2005) |
|
S Lightfoot, R Salowsky, C Buhlmann Breast Cancer Research 2005, 7(Suppl 2):P7.05 (17 June 2005) |
|
Morphogenesis of the mammary gland and the role of keratin expression A Aldahmash, D Lunny, B Lane Breast Cancer Research 2005, 7(Suppl 2):P3.09 (17 June 2005) |